Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Short term Debt: 2020-2023

Historic Short term Debt for Eton Pharmaceuticals (ETON) over the last 4 years, with Dec 2023 value amounting to $5.4 million.

  • Eton Pharmaceuticals' Short term Debt fell 32.70% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 32.70%. This contributed to the annual value of $5.4 million for FY2023, which is 420.81% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Short term Debt stood at $5.4 million for FY2023, which was up 420.81% from $1.0 million recorded in FY2022.
  • Eton Pharmaceuticals' 5-year Short term Debt high stood at $5.4 million for FY2023, and its period low was $280,000 during FY2020.
  • In the last 3 years, Eton Pharmaceuticals' Short term Debt had a median value of $1.4 million in 2021 and averaged $2.6 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' Short term Debt fell by 27.15% in 2022 and then skyrocketed by 420.81% in 2023.
  • Over the past 4 years, Eton Pharmaceuticals' Short term Debt (Yearly) stood at $280,000 in 2020, then surged by 406.43% to $1.4 million in 2021, then declined by 27.15% to $1.0 million in 2022, then skyrocketed by 420.81% to $5.4 million in 2023.